About Armozyme

Armozyme Inc. is an enzyme enhancement company focused on improving the lives of people with diabetes. With Armozyme’s superior enzymes, continuous glucose monitoring systems will become accurate and the new standard in bloodless, painless, and reliable diabetic care.

Armozyme was incorporated in October, 2008 in Delaware and headquartered in Irvine, California. The company is fully funded by the United American Ventures. For investor inquiries or more information about the company, please visit United American Ventures website or email reception@UnitedAmericanVentures.com.